-
1
-
-
0033305438
-
Estrogen receptor null mice: What have we learned and where will they lead us?
-
Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358-417.
-
(1999)
Endocr Rev
, vol.20
, pp. 358-417
-
-
Couse, J.F.1
Korach, K.S.2
-
2
-
-
0033649417
-
Developmental, cellular, and molecular basis of human breast cancer
-
Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 2000;(27):17-37.
-
(2000)
J Natl Cancer Inst Monogr
, vol.27
, pp. 17-37
-
-
Russo, J.1
Hu, Y.F.2
Yang, X.3
Russo, I.H.4
-
3
-
-
0035945656
-
Estrogen and the risk of breast cancer
-
Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.
-
(2001)
N Engl J Med
, vol.344
, pp. 276-285
-
-
Clemons, M.1
Goss, P.2
-
5
-
-
30944469849
-
Estrogen carcinogenesis in breast cancer
-
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
-
(2006)
N Engl J Med
, vol.354
, pp. 270-282
-
-
Yager, J.D.1
Davidson, N.E.2
-
6
-
-
0034992614
-
Molecular and pharmacological aspects of antiestrogen resistance
-
Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN, et al. Molecular and pharmacological aspects of antiestrogen resistance. J Steroid Biochem Mol Biol 2001;76:71-84.
-
(2001)
J Steroid Biochem Mol Biol
, vol.76
, pp. 71-84
-
-
Clarke, R.1
Skaar, T.C.2
Bouker, K.B.3
Davis, N.4
Lee, Y.R.5
Welch, J.N.6
-
7
-
-
0036488531
-
Endocrine-responsive breast cancer and strate-gies for combating resistance
-
Ali S, Coombes RC. Endocrine-responsive breast cancer and strate-gies for combating resistance. Nat Rev Cancer 2002;2:101-12.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 101-112
-
-
Ali, S.1
Coombes, R.C.2
-
8
-
-
0037434618
-
Selective estrogen-receptor modulators -mechanismsof action and application toclinical practice
-
Riggs BL, Hartmann LC. Selective estrogen-receptor modulators -mechanismsof action and application toclinical practice. N Engl J Med 2003;348:618-29.
-
(2003)
N Engl J Med
, vol.348
, pp. 618-629
-
-
Riggs, B.L.1
Hartmann, L.C.2
-
9
-
-
38449122235
-
Estrogen receptors in resistance to hormone therapy
-
Herynk MH, Fuqua SA. Estrogen receptors in resistance to hormone therapy. Adv Exp Med Biol 2007;608:130M43.
-
(2007)
Adv Exp Med Biol
, vol.608
-
-
Herynk, M.H.1
Fuqua, S.A.2
-
10
-
-
79551576468
-
Mechanisms of endocrine resistance in breast cancer
-
Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 2011;62:233-47.
-
(2011)
Annu Rev Med
, vol.62
, pp. 233-247
-
-
Osborne, C.K.1
Schiff, R.2
-
11
-
-
12144269500
-
Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer
-
Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 2005;11:865s-70s.
-
(2005)
Clin Cancer Res
, vol.11
-
-
Osborne, C.K.1
Shou, J.2
Massarweh, S.3
Schiff, R.4
-
12
-
-
25844500946
-
Consensus statement. Workshop on therapeutic resistance in breast cancer: Impact of growth factor signalling pathways and impli-cations for future treatment
-
Gee JM, Howell A, Gullick WJ, Benz CC, Sutherland RL, Santen RJ, et al. Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and impli-cations for future treatment. Endocr Relat Cancer 2005;12 Suppl 1: S1-7.
-
(2005)
Endocr Relat Cancer
, vol.12
, Issue.SUPPL. 1
-
-
Gee, J.M.1
Howell, A.2
Gullick, W.J.3
Benz, C.C.4
Sutherland, R.L.5
Santen, R.J.6
-
13
-
-
34347395733
-
Trastuzumab-mechanism of action and use in clinical practice
-
Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med 2007;357:39-51.
-
(2007)
N Engl J Med
, vol.357
, pp. 39-51
-
-
Hudis, C.A.1
-
14
-
-
0034667395
-
Inhibition of HER2/neu (erb B-2) and mitogen-activat-ed protein kinases enhances tamoxifen action against HER2-over-expressing, tamoxifen-resistant breast cancer cells
-
Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, et al. Inhibition of HER2/neu (erb B-2) and mitogen-activat-ed protein kinases enhances tamoxifen action against HER2-over-expressing, tamoxifen-resistant breast cancer cells. Cancer Res 2000;60:5887-94.
-
(2000)
Cancer Res
, vol.60
, pp. 5887-5894
-
-
Kurokawa, H.1
Lenferink, A.E.2
Simpson, J.F.3
Pisacane, P.I.4
Sliwkowski, M.X.5
Forbes, J.T.6
-
16
-
-
2942652871
-
Mechanisms of tamoxifen resistance: Increased estrogen receptor-her2neu cross-talk in erher2-positive breast cancer
-
Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Can-cer Inst 2004;96:926-35.
-
(2004)
J Natl Can-cer Inst
, vol.96
, pp. 926-935
-
-
Shou, J.1
Massarweh, S.2
Osborne, C.K.3
Wakeling, A.E.4
Ali, S.5
Weiss, H.6
-
17
-
-
4444278403
-
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A southwest oncology group study
-
Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, et al. HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. Clin Cancer Res 2004;10:5670-6.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5670-5676
-
-
Arpino, G.1
Green, S.J.2
Allred, D.C.3
Lew, D.4
Martino, S.5
Osborne, C.K.6
-
18
-
-
0031015394
-
Enhanced anti-prolifer-ative activity of the combination of tamoxifen plus HER-2-neu anti-body
-
Witters LM, Kumar R, Chinchilli VM, Lipton A. Enhanced anti-prolifer-ative activity of the combination of tamoxifen plus HER-2-neu anti-body. Breast Cancer Res Treat 1997;42:1-5.
-
(1997)
Breast Cancer Res Treat
, vol.42
, pp. 1-5
-
-
Witters, L.M.1
Kumar, R.2
Chinchilli, V.M.3
Lipton, A.4
-
19
-
-
0027074588
-
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
-
Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat 1992;24:85-95.
-
(1992)
Breast Cancer Res Treat
, vol.24
, pp. 85-95
-
-
Benz, C.C.1
Scott, G.K.2
Sarup, J.C.3
Johnson, R.M.4
Tripathy, D.5
Coronado, E.6
-
20
-
-
0033050838
-
Tamoxifen resistant breast cancer: Coregulators determine the direction of transcription by antagonist-occupied steroid receptors
-
Takimoto GS, Graham JD, Jackson TA, Tung L, Powell RL, Horwitz LD, et al. Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors. J Steroid Biochem Mol Biol 1999;69:45-50.
-
(1999)
J Steroid Biochem Mol Biol
, vol.69
, pp. 45-50
-
-
Takimoto, G.S.1
Graham, J.D.2
Jackson, T.A.3
Tung, L.4
Powell, R.L.5
Horwitz, L.D.6
-
21
-
-
0001392322
-
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
-
Font de Mora J, Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 2000;20:5041-7.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 5041-5047
-
-
Font De Mora, J.1
Brown, M.2
-
22
-
-
0037420192
-
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
-
Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, et al.Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 2003;95:353-61.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 353-361
-
-
Osborne, C.K.1
Bardou, V.2
Hopp, T.A.3
Chamness, G.C.4
Hilsenbeck, S.G.5
Fuqua, S.A.6
-
23
-
-
0030249381
-
Theroleofgeneralinitiationfactorsintranscriptionby RNA polymerase II
-
Roeder RG.Theroleofgeneralinitiationfactorsintranscriptionby RNA polymerase II. Trends Biochem Sci 1996;21:327-35.
-
(1996)
Trends Biochem Sci
, vol.21
, pp. 327-335
-
-
Roeder, R.G.1
-
24
-
-
0032450899
-
Role of general and gene-specific cofactors in the regu-lation of eukaryotic transcription
-
Roeder RG. Role of general and gene-specific cofactors in the regu-lation of eukaryotic transcription. Cold Spring Harb Symp Quant Biol 1998;63:201-18.
-
(1998)
Cold Spring Harb Symp Quant Biol
, vol.63
, pp. 201-218
-
-
Roeder, R.G.1
-
25
-
-
13044271699
-
Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer
-
Zhu Y, Qi C, Jain S, Le Beau MM, Espinosa R III, Atkins GB, et al. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. Proc Natl Acad Sci U S A 1999;96:10848-53.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 10848-10853
-
-
Zhu, Y.1
Qi, C.2
Jain, S.3
Le Beau, M.M.4
Espinosa Iii., R.5
Atkins, G.B.6
-
26
-
-
0034617082
-
Func-tional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex
-
Burakov D, Wong CW, Rachez C, Cheskis BJ, Freedman LP. Func-tional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J Biol Chem 2000;275:20928-34.
-
(2000)
J Biol Chem
, vol.275
, pp. 20928-20934
-
-
Burakov, D.1
Wong, C.W.2
Rachez, C.3
Cheskis, B.J.4
Freedman, L.P.5
-
27
-
-
0035968333
-
Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta
-
Warnmark A, Almlof T, Leers J, Gustafsson JA, Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta. J Biol Chem 2001;276:23397-404.
-
(2001)
J Biol Chem
, vol.276
, pp. 23397-23404
-
-
Warnmark, A.1
Almlof, T.2
Leers, J.3
Gustafsson, J.A.4
Treuter, E.5
-
28
-
-
0037022631
-
The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alphaand betathroughthe TRAP220subunitand directlyenhances estrogen receptor function in vitro
-
Kang YK, Guermah M, Yuan CX, Roeder RG. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alphaand betathroughthe TRAP220subunitand directlyenhances estrogen receptor function in vitro. Proc Natl Acad Sci U S A 2002;99:2642-7.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 2642-2647
-
-
Kang, Y.K.1
Guermah, M.2
Yuan, C.X.3
Roeder, R.G.4
-
29
-
-
21244466640
-
MED1/TRAP220 exists predominantly in a TRAP/Mediator sub-population enriched in RNA polymerase II and is required for ER-mediated transcription
-
Zhang X, Krutchinsky A, Fukuda A, Chen W, Yamamura S, Chait BT, et al. MED1/TRAP220 exists predominantly in a TRAP/Mediator sub-population enriched in RNA polymerase II and is required for ER-mediated transcription. Mol Cell 2005;19:89-100.
-
(2005)
Mol Cell
, vol.19
, pp. 89-100
-
-
Zhang, X.1
Krutchinsky, A.2
Fukuda, A.3
Chen, W.4
Yamamura, S.5
Chait, B.T.6
-
30
-
-
77951032219
-
Keyrolesfor MED1 Lxx LL motifs in pubertal mammary gland development and luminal-cell differentiation
-
Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, et al. Keyrolesfor MED1 Lxx LL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A 2010;107:6765-70.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 6765-6770
-
-
Jiang, P.1
Hu, Q.2
Ito, M.3
Meyer, S.4
Waltz, S.5
Khan, S.6
-
31
-
-
2242451441
-
Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase
-
Misra P, Owuor ED, Li W, Yu S, Qi C, Meyer K, et al. Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase. J Biol Chem 2002;277:48745-54.
-
(2002)
J Biol Chem
, vol.277
, pp. 48745-48754
-
-
Misra, P.1
Owuor, E.D.2
Li, W.3
Yu, S.4
Qi, C.5
Meyer, K.6
-
32
-
-
28544440730
-
Activation of TRAP/mediatorsubunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation
-
Pandey PK, Udayakumar TS, Lin X, Sharma D, Shapiro PS, Fondell JD. Activation of TRAP/mediatorsubunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation. Mol Cell Biol 2005;25:10695-710.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 10695-10710
-
-
Pandey, P.K.1
Udayakumar, T.S.2
Lin, X.3
Sharma, D.4
Shapiro, P.S.5
Fondell, J.D.6
-
33
-
-
44949188489
-
MED1 phos-phorylation promotes its association with mediator: Implications for nuclear receptorsignaling
-
Belakavadi M, Pandey PK, Vijayvargia R, Fondell JD. MED1 phos-phorylation promotes its association with mediator: implications for nuclear receptorsignaling. Mol Cell Biol 2008;28:3932-42.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 3932-3942
-
-
Belakavadi, M.1
Pandey, P.K.2
Vijayvargia, R.3
Fondell, J.D.4
-
34
-
-
79958864543
-
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth
-
Chen Z, Zhang C, Wu D, Chen H, Rorick A, Zhang X, et al. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J 2011;30:2405-19.
-
(2011)
EMBO J
, vol.30
, pp. 2405-2419
-
-
Chen, Z.1
Zhang, C.2
Wu, D.3
Chen, H.4
Rorick, A.5
Zhang, X.6
-
35
-
-
0036648452
-
Amplification and expression of genes from the 17q11 approximately q12 amplicon in breast cancer cells
-
Luoh SW. Amplification and expression of genes from the 17q11 approximately q12 amplicon in breast cancer cells. Cancer Genet Cytogenet 2002;136:43-7.
-
(2002)
Cancer Genet Cytogenet
, vol.136
, pp. 43-47
-
-
Luoh, S.W.1
-
36
-
-
26444546442
-
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
-
Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005;102:13550-5.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 13550-13555
-
-
Miller, L.D.1
Smeds, J.2
George, J.3
Vega, V.B.4
Vergara, L.5
Ploner, A.6
-
37
-
-
33751261643
-
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
-
Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006;66:10292-301.
-
(2006)
Cancer Res
, vol.66
, pp. 10292-10301
-
-
Ivshina, A.V.1
George, J.2
Senko, O.3
Mow, B.4
Putti, T.C.5
Smeds, J.6
-
38
-
-
4544376914
-
Binding at and transactivation of the COX-2 promoter by nucleartyrosine kinase receptor Erb B-2
-
Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, et al. Binding at and transactivation of the COX-2 promoter by nucleartyrosine kinase receptor Erb B-2. Cancer Cell 2004;6:251-61.
-
(2004)
Cancer Cell
, vol.6
, pp. 251-261
-
-
Wang, S.C.1
Lien, H.C.2
Xia, W.3
Chen, I.F.4
Lo, H.W.5
Wang, Z.6
-
39
-
-
79955962062
-
ARGLU1 interacts with MED1 and is required forestrogen receptor-mediated genetranscription and breast cancer cell growth
-
Zhang D, Jiang P, Xu Q, Zhang X. ARGLU1 interacts with MED1 and is required forestrogen receptor-mediated genetranscription and breast cancer cell growth. J Biol Chem 2011;286:17746-54.
-
(2011)
J Biol Chem
, vol.286
, pp. 17746-17754
-
-
Zhang, D.1
Jiang, P.2
Xu, Q.3
Zhang, X.4
-
40
-
-
77957673898
-
Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance
-
Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, et al. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev 2011;24: 2219-27.
-
(2011)
Genes Dev
, vol.24
, pp. 2219-2227
-
-
Lupien, M.1
Meyer, C.A.2
Bailey, S.T.3
Eeckhoute, J.4
Cook, J.5
Westerling, T.6
-
41
-
-
0033637703
-
Cofactordynamicsand sufficiency in estrogen receptor-regulated transcription
-
Shang Y, Hu X, Di Renzo J, Lazar MA, Brown M.Cofactordynamicsand sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-52.
-
(2000)
Cell
, vol.103
, pp. 843-852
-
-
Shang, Y.1
Hu, X.2
Di Renzo, J.3
Ma, L.4
Brown, M.5
-
42
-
-
57349113761
-
Regulation of ERBB2 by oestrogen receptor-PAX2 determines responsetotamoxifen
-
Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines responsetotamoxifen. Nature 2008;456:663-6.
-
(2008)
Nature
, vol.456
, pp. 663-666
-
-
Hurtado, A.1
Holmes, K.A.2
Geistlinger, T.R.3
Hutcheson, I.R.4
Nicholson, R.I.5
Brown, M.6
-
43
-
-
0030946198
-
Coactivator and corepressor regulationoftheagonist/ antagonistactivityofthemixedantiestrogen, 4-hydroxytamoxifen
-
Smith CL, Nawaz Z, O'Malley BW. Coactivator and corepressor regulationoftheagonist/antagonistactivityofthemixedantiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997;11:657-66.
-
(1997)
Mol Endocrinol
, vol.11
, pp. 657-666
-
-
Smith, C.L.1
Nawaz, Z.2
O'Malley, B.W.3
-
44
-
-
22344435852
-
Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-Co R and SMRT
-
Keeton EK, Brown M. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-Co R and SMRT. Mol Endocrinol 2005;19:1543-54.
-
(2005)
Mol Endocrinol
, vol.19
, pp. 1543-1554
-
-
Keeton, E.K.1
Brown, M.2
-
45
-
-
0037192501
-
Moleculardeterminantsforthetissuespecificityof SERMs
-
Shang Y, Brown M. Moleculardeterminantsforthetissuespecificityof SERMs. Science 2002;295:2465-8.
-
(2002)
Science
, vol.295
, pp. 2465-2468
-
-
Shang, Y.1
Brown, M.2
-
46
-
-
0029877913
-
Activation of the unli-ganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
-
Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unli-ganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-83.
-
(1996)
EMBO J
, vol.15
, pp. 2174-2183
-
-
Bunone, G.1
Briand, P.A.2
Miksicek, R.J.3
Picard, D.4
-
47
-
-
0035668047
-
Cross-talk among estrogen receptor, epidermalgrowthfactor, andinsulin-likegrowthfactorsignalinginbreast cancer
-
discussion 11s-12s
-
Lee AV, Cui X, Oesterreich S. Cross-talk among estrogen receptor, epidermalgrowthfactor, andinsulin-likegrowthfactorsignalinginbreast cancer. Clin Cancer Res 2001;7:4429s-35s; discussion 11s-12s.
-
(2001)
Clin Cancer Res
, vol.7
-
-
Lee, A.V.1
Cui, X.2
Oesterreich, S.3
-
48
-
-
51649091930
-
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
-
Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008;26:4078-85.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4078-4085
-
-
Creighton, C.J.1
Casa, A.2
Lazard, Z.3
Huang, S.4
Tsimelzon, A.5
Hilsenbeck, S.G.6
-
49
-
-
84856008906
-
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
-
Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012;481:389-93.
-
(2012)
Nature
, vol.481
, pp. 389-393
-
-
Ross-Innes, C.S.1
Stark, R.2
Teschendorff, A.E.3
Holmes, K.A.4
Ali, H.R.5
Dunning, M.J.6
|